nach oben

World Journal of Urology

Erschienen in:

01.10.2015 | Original Article

Phosphodiesterase type 2 distribution in the guinea pig urinary bladder

verfasst von: M. S. Rahnama’i, R. Hohnen, Ph. E. V. Van Kerrebroeck, G. A. van Koeveringe

Erschienen in: World Journal of Urology | Ausgabe 10/2015

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Nitric oxide-stimulated cGMP synthesis represents an important signalling pathway in the urinary bladder. Inhibitors of the PDE1 and PDE5 enzyme have been studied to treat storage and voiding disorders in clinical settings. The distribution of PDE2 in the bladder is unknown. This study focuses on the distribution and site of action of PDE2 within the guinea pig urinary bladder wall.

Methods

Six male guinea pig bladders were dissected and treated in 2 ml Krebs’ solution and 10 µM of the specific PDE2 inhibitor, Bay 60-7550 at 36 °C for 30 min. After stimulating tissues with 100 µM of diethylamine-NONOate for 10 min, the tissues were snap frozen and cut in 10 µm sections which were examined for cGMP immune-reactivity, co-stained with either vimentin, synaptic vesicle protein 2, calcitonin gene-related protein and protein gene product 9.5.

Results

PDE2 inhibitor Bay 60-7550 inhibits cGMP breakdown the most in the urothelial and suburothelial layers, as well as on the nerve fibres. After inhibition by Bay 60-7550, cGMP was mainly expressed in the intermuscle interstitial cells and the nerve fibres of the outer muscle layers of lateral wall, indicating the presence of PDE2 activity.

Discussion and conclusion

Our study is the first to show the distribution of PDE2 in the bladder which was shown to be present in the urothelium, mainly umbrella cells, the interstitial cells of the suburothelium and the outer muscle, as well as in nerve fibres.

Smet PJ, Jonavicius J, Marshall VR, de Vente J (1996) Distribution of nitric oxide synthase-immunoreactive nerves and identification of the cellular targets of nitric oxide in guinea-pig and human urinary bladder by cGMP immunohistochemistry. Neuroscience 71(2):337–348CrossRefPubMed

Gillespie JI, Drake MJ (2004) The actions of sodium nitroprusside and the phosphodiesterase inhibitor dipyridamole on phasic activity in the isolated guinea-pig bladder. BJU Int 93(6):851–858CrossRefPubMed

de Jongh R, van Koeveringe GA, van Kerrebroeck PE, Markerink-van Ittersum M, de Vente J, Gillespie JI (2007) Alterations to network of NO/cGMP-responsive interstitial cells induced by outlet obstruction in guinea-pig bladder. Cell Tissue Res 330(1):147–160CrossRefPubMed

Gillespie JI, Markerink-van Ittersum M, De Vente J (2006) Endogenous nitric oxide/cGMP signalling in the guinea pig bladder: evidence for distinct populations of sub-urothelial interstitial cells. Cell Tissue Res 325(2):325–332CrossRefPubMed

Gillespie JI, Markerink-van Ittersum M, de Vente J (2005) Expression of neuronal nitric oxide synthase (nNOS) and nitric-oxide-induced changes in cGMP in the urothelial layer of the guinea pig bladder. Cell Tissue Res 321(3):341–351CrossRefPubMed

Gillespie JI, Markerink-van Ittersum M, de Vente J (2004) cGMP-generating cells in the bladder wall: identification of distinct networks of interstitial cells. BJU Int 94(7):1114–1124CrossRefPubMed

Beavo JA (1995) Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 75(4):725–748PubMed

de Vente J, Markerink-vanIttersum M, Vles JS (2006) The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord. J Chem Neuroanat 31(4):275–303CrossRefPubMed

Archer SL, Michelakis ED (2009) Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension. N Engl J Med 361(19):1864–1871CrossRefPubMed

10.

Rosenzweig EB (2010) Tadalafil for the treatment of pulmonary arterial hypertension. Expert Opin Pharmacother 11(1):127–132. doi:10.1517/14656560903413542 CrossRefPubMed

11.

Feldman AM, McNamara DM (2002) Reevaluating the role of phosphodiesterase inhibitors in the treatment of cardiovascular disease. Clin Cardiol 25(6):256–262CrossRefPubMed

12.

Halene TB, Siegel SJ (2007) PDE inhibitors in psychiatry: future options for dementia, depression and schizophrenia? Drug Discov Today 12(19–20):870–878CrossRefPubMed

13.

Morales AM, Mirone V, Dean J, Costa P (2009) Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence. Clin Interv Aging 4:463–472PubMedCentralCrossRefPubMed

14.

Rowlands TE, Donnelly R (2007) Medical therapy for intermittent claudication. Eur J Vasc Endovasc Surg 34(3):314–321CrossRefPubMed

15.

Rahnama’i MS, Uckert S, Hohnen R, van Koeveringe GA (2013) The role of phosphodiesterases in bladder pathophysiology. Nat Rev Urol 10(7):414–424CrossRefPubMed

16.

Uckert S, Kuczyk MA, Oelke M (2013) Phosphodiesterase inhibitors in clinical urology. Expert Rev Clin Pharmacol 6(3):323–332CrossRefPubMed

17.

Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC et al (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64(1):118–140CrossRefPubMed

18.

Fock EM, Lavrova EA, Bachteeva VT, Chernigovskaya EV, Parnova RG (2004) Nitric oxide inhibits arginine-vasotocin-induced increase of water osmotic permeability in frog urinary bladder. Pflug Arch 448(2):197–203CrossRef

19.

Zhai K, Chang Y, Wei B, Liu Q, Leblais V, Fischmeister R et al (2014) Phosphodiesterase types 3 and 4 regulate the phasic contraction of neonatal rat bladder smooth myocytes via distinct mechanisms. Cell Signal 26(5):1001–1010CrossRefPubMed

20.

Truss MC, Uckert S, Stief CG, Forssmann WG, Jonas U (1996) Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle. II. Effect of various PDE inhibitors on smooth muscle tone and cyclic nucleotide levels in vitro. Urol Res 24(3):129–134CrossRefPubMed

21.

Uckert S, Kuthe A, Jonas U, Stief CG (2001) Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate. J Urol 166(6):2484–2490CrossRefPubMed

22.

Podzuweit T, Nennstiel P, Muller A (1995) Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine. Cell Signal 7(7):733–738CrossRefPubMed

23.

Boess FG, Hendrix M, van der Staay FJ, Erb C, Schreiber R, van Staveren W et al (2004) Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance. Neuropharmacology 47(7):1081–1092CrossRefPubMed

24.

Rahnama’i MS, van Koeveringe GA, Hohnen R, Ona S, van Kerrebroeck PE, de Wachter SG (2013) Distribution of phosphodiesterase type 5 (PDE5) in the lateral wall of the guinea pig urinary bladder. BJU Int 112(2):246–257CrossRefPubMed

25.

de Vente J, Markerink-van Ittersum M, Axer H, Steinbusch HW (2001) Nitric-oxide-induced cGMP synthesis in cholinergic neurons in the rat brain. Exp Brain Res 136(4):480–491CrossRefPubMed

26.

van Staveren WC, Steinbusch HW, Markerink-van Ittersum M, de Behrends S, Vente J (2004) Species differences in the localization of cGMP-producing and NO-responsive elements in the mouse and rat hippocampus using cGMP immunocytochemistry. Eur J Neurosci 19(8):2155–2168CrossRefPubMed

27.

Himms-Hagen J, Cui J, Lynn Sigurdson S (1990) Sympathetic and sensory nerves in control of growth of brown adipose tissue: effects of denervation and of capsaicin. Neurochem Int 17(2):271–279CrossRefPubMed

28.

Kong JH, Adelman JP, Fuchs PA (2008) Expression of the SK2 calcium-activated potassium channel is required for cholinergic function in mouse cochlear hair cells. J Physiol 586(Pt 22):5471–5485PubMedCentralCrossRefPubMed

29.

Kuniyoshi K, Ohtori S, Ochiai N, Murata R, Matsudo T, Yamada T et al (2007) Characteristics of sensory DRG neurons innervating the wrist joint in rats. Eur J Pain 11(3):323–328CrossRefPubMed

30.

Ramos-Vara JA, Miller MA (2007) Immunohistochemical detection of protein gene product 9.5 (PGP 9.5) in canine epitheliotropic T-cell lymphoma (mycosis fungoides). Vet Pathol 44(1):74–79CrossRefPubMed

31.

Sadhu K, Hensley K, Florio VA, Wolda SL (1999) Differential expression of the cyclic GMP-stimulated phosphodiesterase PDE2A in human venous and capillary endothelial cells. J Histochem Cytochem 47(7):895–906CrossRefPubMed

32.

Rahnama’i MS, van Koeveringe GA, Essers PB, de Wachter SG, de Vente J, van Kerrebroeck PE et al (2010) Prostaglandin receptor EP1 and EP2 site in guinea pig bladder urothelium and lamina propria. J Urol 183(3):1241–1247. doi:10.1016/j.juro.2009.11.004 CrossRefPubMed

33.

Lagou M, Drake MJ, Markerink-Van Ittersum M, De Vente J, Gillespie JI (2006) Interstitial cells and phasic activity in the isolated mouse bladder. BJU Int 98(3):643–650CrossRefPubMed

34.

Park H, Clark E, Conklin JL (2003) Effects of phosphodiesterase inhibitors on oesophageal neuromuscular functions. Neurogastroenterol Motil 15(6):625–633CrossRefPubMed

35.

de Groat WC, Yoshimura N (2009) Afferent nerve regulation of bladder function in health and disease. Handb Exp Pharmacol 194:91–138CrossRefPubMed

36.

Birder LA (2006) Urinary bladder urothelium: molecular sensors of chemical/thermal/mechanical stimuli. Vasc Pharmacol 45(4):221–226CrossRef

37.

Smet PJ, Moore KH, Jonavicius J (1997) Distribution and colocalization of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder. Lab Invest 77(1):37–49PubMed

Titel: Phosphodiesterase type 2 distribution in the guinea pig urinary bladder
verfasst von: M. S. Rahnama’i
R. Hohnen
Ph. E. V. Van Kerrebroeck
G. A. van Koeveringe
Publikationsdatum: 01.10.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 10/2015
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-014-1455-6

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Introduction

Methods

Results

Discussion and conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2015

Perioperative and long-term renal functional outcomes of robotic versus laparoscopic partial nephrectomy: a multicenter matched-pair comparison

Estimated functional renal parenchymal volume predicts the split renal function following renal surgery

Physical activity and body mass index as predictors of prostate cancer risk

Significant increase in detection of prostate cancer recurrence following radical prostatectomy with an early imaging acquisition protocol with 18F-fluorocholine positron emission tomography/computed tomography